About
Process
Fund
Media
GenInnov Thoughts
Contact Us
About
Fund
GenInnov Thoughts
Micro-personalized Health
Categories
Silicon Shock
Custom Chips
2026's Two Races
Changing Internet
Unstructured Times
Macro Policies
Agentic AI
Physical AI
Super Moore Era
Competitive World
Generative Analysts (GenRAs)
Edge Computing
Beyond XaaS Model
Old AI vs. New AI
Machine Innovators
Micro-personalized Health
Humanoid Age
Large, Long-term Innovations
Instant Copiability
Hardware/Software Flip
Polyglot Machines
Transformer Math
Innovation Era
The Fourth Macro Sector
GenAI Revolution
Nilesh Jasani
·
September 18, 2025
AI’s Seven Redeeming Virtues
After our Sins essay, the predicted counter. It may be less compulsively readable, but its perspective is more necessary for its rarity
Nilesh Jasani
·
August 21, 2024
“Time forgot its own shadow”
The profound statement in the title evokes a world where the past has no presence, the present is untethered, and the future becomes a void, questioning the essence of existence itself. In reality,...
Nilesh Jasani
·
July 16, 2023
A typical week, a busy week
Generative AI innovations: Google Bard's 43 languages, Meta's CM3leon, ChatGPT in healthcare, NVidia biotech investments, AI in drug discovery, and synthetic data in the automotive sector.
Nilesh Jasani
·
July 10, 2023
AI, UBI et al with Japan
Explore the cosmic imperative and future of humanity with AI. From Universal Basic Income to AI ethics, delve into Japan and China’s strategic leaps.
Nilesh Jasani
·
July 1, 2023
Healthcare's ChatGPT?
Discover the impact of generative AI in drug discovery. Learn how Transformer models and AI-designed molecules are revolutionizing the pharmaceutical industry.
Articles on innovation
Our Latest Articles
Gary Pinge
·
January 29, 2026
China’s Pharma Foundry
The untold story of how contract labs became a pharmaceutical superpower. China didn't just join the drug discovery race; it rewrote the rules.
Archisha Mukherjee
·
January 22, 2026
The Accelerationist State: China’s Biopharma Industrialization
China’s biopharma surge is policy-made: statutory clocks, silent approvals, and scaled expertise—creating a pipeline too fast to ignore
Nilesh Jasani
·
January 16, 2026
Alibaba: The AI Kingmaker
When the premier model-maker is the top cloud provider, it becomes the backbone of the world's most AI-enthusiastic society.
View More
Stay Informed with GenInnov
Success! thank you for your submission!
Oh no! Something went wrong.
To contact us for information about the GenInnov Funds,
contact us